Improved conditional expression systems resulting in physiological level of HNF4α expression confirm HNF4α induced apoptosis in the pancreatic β-cell line INS-1 by Senkel, Sabine et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Research Notes
Open Access Technical Note
Improved conditional expression systems resulting in physiological 
level of HNF4α expression confirm HNF4α induced apoptosis in the 
pancreatic β-cell line INS-1
Sabine Senkel, Christoph Waldner, Gerhart U Ryffel and Heike Thomas*
Address: Institut für Zellbiologie (Tumorforschung), Universitätsklinikum Essen, Universität, Duisburg-Essen, D-45122 Essen, Germany
Email: Sabine Senkel - sabine.senkel@uni-due.de; Christoph Waldner - christoph.waldner@uni-due.de; Gerhart U Ryffel - gerhart.ryffel@uni-
due.de; Heike Thomas* - heike.thomas@uni-due.de
* Corresponding author    
Abstract
Background: To analyze gene function in mammalian cells tetracycline inducible expression of a
gene-of-interest at a specific genomic location (Flp-In T-REx™) is most attractive. However,
leakiness of basal transgene expression and artificially high expression level upon tetracycline
addition may be disadvantageous.
Findings: To solve these problems, we developed two different approaches to improve our
pancreatic β-cell line INS-1 Flp-In T-REx™ expressing the tissue restricted transcription factor
HNF4α under control of tetracycline. On the one hand we replaced the strong full length CMV
promoter (CMV-Wt) with a weaker 5'-deleted CMV promoter fragment of 138 nucleotides in
length (CMV-138). On the other hand we extended our INS-1 Flp-In T-REx™ cell lines with a
Shield-1 dependent conditional control system of protein stability. Therefore, we fused HNF4α to
the destabilization domain (DD) deduced from human FKBP12 protein. As a result in both
approaches basal transgene expression level was markedly reduced, but HNF4α induction could
still be maintained. Additionally, we could show that a low increase in HNF4α induces caspase
activity indicating an apoptotic effect of HNF4α in these cells.
Conclusion: In the present study we considerably improved our INS-1 Flp-In T-REx™ cell lines
conditionally expressing HNF4α to reduce leakiness and to optimize exogenous HNF4α protein
expression to a physiological level. As an important result we could extend our previous results
that HNF4α induces apoptosis in the pancreatic β-cell line INS-1 with the new aspect that an
expression level of the HNF4α transgene marginally exceeding the endogenous level is sufficient to
trigger apoptosis.
Background
Stable integration of inducible transcription factors is
widely used to analyze gene function in mammalian cells.
Among others the most commonly used system is the tet-
racycline inducible expression system. Based on repres-
sion by the Tet-repressor (TetR) the Flp-In T-REx™ system
(Invitrogen) uses a full-length CMV promoter that con-
tains two tetO sequences in tandem and a genomic inte-
grated FRT site that can be used to integrate any gene-of-
interest by Flp recombinase mediated integration. A limi-
Published: 17 October 2009
BMC Research Notes 2009, 2:210 doi:10.1186/1756-0500-2-210
Received: 8 July 2009
Accepted: 17 October 2009
This article is available from: http://www.biomedcentral.com/1756-0500/2/210
© 2009 Thomas et al; licensee BioMed Central Ltd. 
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Research Notes 2009, 2:210 http://www.biomedcentral.com/1756-0500/2/210
Page 2 of 7
(page number not for citation purposes)
tation of this system may consist in considerable back-
ground expression without the activator tetracycline and
in artificially high level of protein expression upon activa-
tion (our data).
Recently, another inducible system was developed that
allows conditional protein degradation [1]. The human
FK506- and rapamycin-binding protein (FKBP12) is rap-
idly and constitutively degraded in mammalian cells. Pro-
tein fusion of this destabilizing domain (DD) transfers
the instability and addition of the ligand Shield-1 that
binds to the destabilizing domain, protects the fusion
protein from rapid degradation [1].
The rat pancreatic β-cell line INS-1 has retained many
properties of β-cells including glucose induced insulin
secretion [2] and is frequently used for conditional expres-
sion of introduced genes by the Tet-inducible system (for
references see [3]). However, to overcome clonal differ-
ences by random genomic insertion, we have established
the Flp-In T-REx™ system (Invitrogen) [3] to conditionally
express transcription factors in β-cells [3-5].
The nuclear receptor hepatocyte nuclear factor 4α
(HNF4α) is expressed as isoforms by alternative splicing
and differential promoter usage (P1 and P2 promoter)
[6]. P2 derived transcripts are predominantly expressed in
mammalian  β-cells and corresponding cell lines [7-9].
Heterozygous mutations in the human HNF4α gene lead
to maturity-onset diabetes of the young subtype 1
(MODY1) [6] and there is evidence that HNF4α is also a
susceptibility gene for common type 2 diabetes [10].
Defective regulation by HNF4α has been assumed to con-
tribute to impaired glucose stimulated insulin secretion in
diabetic patients [6]. Additionally, we showed that induc-
ible HNF4α in INS-1 cells changes cell morphology,
decreases proliferation and increases apoptosis [5]. The
splice variant HNF4α2 was more efficient than HNF4α8
[5] reflecting the additional activation domain present in
the HNF4α2 protein derived from the P1 promoter [6].
In the present study we improved our INS-1 Flp-In T-REx™
cell lines to reduce basal transgene expression in the
absence of tetracycline and to limit induced HNF4α
expression to a physiological level.
Results
The Flp-In INS-1 cell lines conditionally expressing HNF4α 
are markedly leaky
Recently, we could improve the Western blot analysis to
compare the expression levels of the endogenous and
exogenous HNF4α protein in INS-1 cell extracts. As
shown in Figure 1 (lane 1) our Flp-In INS-1 cell clone 1-
1.2 showed endogenous expression of the HNF4α pro-
tein, which can be distinguished from the 78 amino acids
larger exogenous protein carrying an N-terminal myc-tag
(lane 2-8). In the uninduced state basal HNF4α transgene
expression markedly exceeds the expression level of the
endogenous HNF4α gene (compare lanes 1 and 2). Upon
induction by tetracycline we estimate an additional 80-
fold up-regulation but such a high overexpression could
result in unphysiological effects of HNF4α in our Flp-In
INS-1 cells.
Flp-In INS-1 cell lines conditionally expressing HNF4α 
from a 5' deleted CMV promoter are less leaky
To decrease the basal HNF4α2 transgene expression in
our Flp-In INS-1 cell lines we replaced the full length CMV
promoter (CMV-Wt) with 5'-deleted CMV promoter frag-
ments of 218 (CMV-218), 138 (CMV-138) or 68 (CMV-
68) nucleotides in length (Figure 2A). Using the CMV-68
construct we failed to establish stable cell lines, possibly
due to the loss of an enhancer activity acting on the hygro-
Western blot analysis of INS-1 cell extracts Figure 1
Western blot analysis of INS-1 cell extracts. Whole 
cell extracts of the indicated Flp-In INS-1 cell lines were ana-
lyzed by Western blotting using the HNF4α-(C-19)-antibody 
(Santa Cruz) recognizing P1 as well as P2 promoter derived 
proteins. The cell line INS-1 HNF4α2 [5] was cultured with-
out (-) or with (+) 50 ng/ml tetracycline for 24 h. 20 μg of 
total protein were loaded. For the induced cell line (+), dif-
ferent amounts of whole cell proteins were used to estimate 
the fold induction of the transgene. The exogenous HNF4α 
protein was cloned C-terminally to six myc tag repeats. 
Therefore, the myc-HNF4α protein has an increased molec-
ular mass of approximately 10 kDa in comparison to the 
endogenous protein. This results in a considerable shift in the 
western blot. The unexpected higher mobility of some minor 
bands of the exogenous HNF4α proteins possibly reflects 
degradation products.
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Improved Flp-In INS-1 cell lines Figure 2
Improved Flp-In INS-1 cell lines. (A) Schematic presentation of the vector construct to generate Flp-In INS-1 cell lines 
conditionally expressing HNF4α under control of the 5'-deleted CMV promoter (left) or the P2 promoter (P2/-2200 from [7]) 
from the human HNF4α gene (right). Both promoters are tetracycline inducible due to the operator sites (2*TetO2) upstream 
of the transcription start site and the constitutively expressed tetracycline repressor (TetR) [3]. (B) Western blotting of whole 
cell extracts of the indicated Flp-In INS-1 cell lines with the HNF4α-antibody C-19 (Santa Cruz) to detect the HNF4α2 splice 
variant expressed from the full length or 5' deleted CMV promoter. Cells were cultured without (- tet) or with (+ tet) 50 ng/
ml tetracycline for 24 h. 18 μg of total protein were loaded per lane and the signal for the exogenous (exo) as well as endog-
enous (endo) HNF4α is marked. Since the Flp-In INS-1 cell line #1-1.2 used previously [3] has lost its glucose induced insulin 
secretion (data not shown), we used now the cell line #5-3.19 that retains glucose sensitivity (data not shown) and that shows 
an identical expression level of endogenous HNF4α (lanes 1 and 2). The observation of differential characteristics in the INS-1 
cells has been observed in our initial study [3] and reflects a property typical of the INS-1 cell line [23].
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mycin resistance gene as well. For cell lines with CMV-Wt,
CMV-218 and CMV-138 constructs basal transgene
expression was dependent on the CMV promoter length
(Figure 2B, top, lane 3-8) with CMV-138 having the low-
est activity. Induction with tetracycline resulted in an
increased HNF4α transgene expression in each cell line
(Figure 2B, bottom, lanes 3-8). Based on these data we
used the CMV-138 promoter to establish cell lines
expressing the HNF4α8 or HNF4α2 isoform derived from
the P2 and P1 promoter, respectively. Figure 3A confirms
the reduced basal transgene expression for the cell lines
α8/CMV-138#1 and #2 in comparison to CMV-Wt (lanes
1 and 8). In both cell lines transgene induction is depend-
ent on tetracycline concentration (Figure 3A, lane 2-7).
Expression of the transgene is comparable to the expres-
sion of the endogenous HNF4α at 5 ng/ml tetracycline for
cell line #1 (lane 4, top) and 2.5 ng/ml tetracycline for cell
line #2 (lane 3, bottom).
Investigating the level of HNF4α protein inducing apop-
totic events we observed a significant increase in caspase
activity starting at a concentration of 5 to 10 ng/ml tetra-
cycline (Figure 3B). At this concentration the expression
level of the HNF4α8 transgene just starts to exceed the
endogenous level of HNF4α (Figure 3A and 3B). The cell
lines containing the HNF4α2 transgene have most similar
properties (data not shown).
In conclusion, our improved experimental system shows
that even a small increase in HNF4α is sufficient to induce
apoptotic effects in the pancreatic β-cell line INS-1.
Long-term induction of the HNF4α transgene leads to its 
downregulation
Upon long-term induction of the INS-1 cell line α2/CMV-
138#1 with 50 ng/ml tetracycline we observed a marked
decrease in HNF4α transgene expression. As shown by
immunostaining (additional file 1, Figure S1), induction
for 2 days resulted in transgene expression in 70% of the
cells, whereas this number was dramatically diminished
to 53%, 4% and 9% after 7, 14 and 23 days of induction,
respectively. We observed this phenomenon also for the
cell lines α2/CMV-138#2 and α2/CMV-Wt (data not
shown) indicating a silencing of the CMV promoter that is
independent of its length.
Induction of apoptosis upon expression of HNF4α8 Figure 3
Induction of apoptosis upon expression of HNF4α8. (A) Western blotting of whole cell extracts of the INS-1 α8/CMV-
138 cell lines (#1 and #2) and the α8/CMV-Wt cell line with the HNF4α-antibody C-19 (Santa Cruz). Cells were cultured with 
the indicated concentrations of tetracycline for 3 days. 20 μg of total protein were loaded per lane and the signal for the exog-
enous (exo) as well as endogenous (endo) HNF4α is marked. (B) Caspase 3/7 activity assay. The indicated INS-1 cell lines were 
treated with the indicated tetracycline concentrations for 3 days, lysed and caspase 3/7 activity was assessed. The relative cas-
pase activity was calculated using the appropriate uninduced cells as a reference. Data are mean ± SD of six determinations and 
significant differences (p-value < 0.01) are indicated with an asterisk.
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Cell lines conditionally expressing a ligand-controlled 
HNF4α8 fusion protein driven by a tetracycline inducible 
P2 promoter activates caspases
As the CMV promoter is downregulated upon long-term
induction, we generated a Flp-In INS-1 cell line expressing
HNF4α8 under control of a tetracycline inducible HNF4α
P2 promoter carrying the tet-operator immediately down-
stream of the TATA box (Figure 2A). As shown in Figure
4A for two independent cell lines, basal HNF4α transgene
expression is high without induction (lane 1 and 3) and
only marginally increased upon addition of tetracycline
(lane 2 and 4). To improve inducibility, we fused the
L106P mutant of the human FKBP12 protein (the destabi-
lizing domain, DD) [1] N-terminal to the myc-tagged
HNF4α8 protein. As shown in Figure 4B, lower panel,
generation of stable cell lines resulted in high expression
of the DD-HNF4α8 fusion protein in more than 70% of
the cells upon induction with tetracycline and Shield-1,
but in the absence of both inducers there is no fusion pro-
tein detectable (Figure 4B, upper panel). This is confirmed
by Western blot analysis (Figure 5A) showing that expres-
sion of the fusion protein is only weak after addition of
tetracycline or Shield-1 alone (lanes 2 and 3), but mark-
edly increased upon addition of both inducers simultane-
ously (lane 4).
To prove the functional properties of the DD-HNF4α pro-
tein we measured the executioner caspases 3 and 7, using
DD-HNF-4α8 wild type in comparison to the C106R
mutant protein, known to impair the DNA binding of
HNF4α [5]. Figure 5B shows that induction of DD-
HNF4α8 wild type with tetracycline and Shield-1 resulted
in a significant increase in caspase activity that was absent
Conditional expression of the DD-HNF4α fusion protein Figure 5
Conditional expression of the DD-HNF4α fusion pro-
tein. (A) Western blotting of whole cell extracts of the INS-
1 P2/DD-HNF4α8 wild type #1 and C106R-mutant cell line 
with the HNF4α-antibody C-19 (Santa Cruz). Cells were cul-
tured without (-) or with (+) 50 ng/ml tetracycline and/or 1 
μM Shield-1 for 5 days. 15 μg of total protein were loaded 
per lane and the signal for the exogenous (exo) as well as 
endogenous (endo) HNF4α is marked. (B) Caspase 3/7 activ-
ity assay. The cells were treated with 50 ng/ml tetracycline 
and/or 1 μM Shield-1 for 5 days, lysed and caspase 3/7 activ-
ity was assessed. The relative caspase activity was calculated 
using the appropriate uninduced cells as a reference. Data 
are mean ± SD of six determinations and significant differ-
ences (p-value < 0.01) are indicated with an asterisk.
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Expression of HNF4α8 under the control of the P2 pro- moter Figure 4
Expression of HNF4α8 under the control of the P2 
promoter. (A) Western blotting of whole cell extracts of 
the INS-1 P2/HNF4α8 cell lines (#1 and #2) with the 
HNF4α-antibody C-19 (Santa Cruz). Cells were cultured 
without (-) or with (+) 50 ng/ml tetracycline for 24 h. 20 μg 
of total protein were loaded per lane and the signal for the 
exogenous (exo) as well as endogenous (endo) HNF4α is 
marked. (B) Immunofluorescence of INS-1 P2/DD-
HNF4α8#1 cells without (upper panel) or with (lower panel) 
induction with 50 ng/ml tetracycline and 1 μM Shield-1 for 45 
h. HNF4α was detected using a myc-tag specific primary anti-
body and a Cy3-coupled secondary antibody (red). The cells 
were also stained with DAPI (blue) to visualize the total 
number of cells. The fusion protein is located in the nucleus 
comparable to the wild type HNF4α protein.
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in the DD-HNF4α8-C106R mutant. Obviously, the mag-
nitude of induction of caspase activity correlates with the
expression level of the DD-HNF4α8 wild type protein
(compare panel A and B in Figure 5). In conclusion, our
results demonstrate that the DD-HNF4α8 wild type pro-
tein is functional and that a small increase in HNF4α
induces caspase activity in the pancreatic β-cell line INS-1.
Discussion
To reduce high basal transgene expression in the absence
of tetracycline (Figure 1, lane 2) and to allow induction at
physiological levels, we decreased the strength of the CMV
promoter by deleting enhancing elements [11] in the INS-
1 Flp-In T-REx™ cell lines that conditionally express
HNF4α [3,5]. For our experiments the CMV-138 pro-
moter construct was optimal as the basal activity was
reduced to a level below endogenous HNF4α expression,
but still gave several fold induction (Figure 2 and 3). The
most suitable CMV promoter deletion must be chosen for
each experiment, as in HEK293 cells conditional expres-
sion of HNF4α showed a low background even using the
full-length CMV promoter [12].
In the second approach we constructed a destabilized DD-
HNF4α fusion protein that could successfully be stabi-
lized by addition of Shield-1. This system seems to be
applicable for many different proteins [1,13-16] and we
used it, since tetracycline induced expression using the P2
promoter was inefficient (Figure 4A). We could prove that
the DD-HNF4α fusion protein retains its biological prop-
erty, because it induces apoptosis in INS-1 cells upon
Shield-1 addition (Figure 5B) and transactivates a luci-
ferase reporter gene driven by the human HNF1-promoter
containing one HNF4 binding site (data not shown).
Upon long-term induction of the CMV promoter by tetra-
cycline we observed silencing of transgene expression
which did not occur, if the cells were cultured without tet-
racycline. It is likely that this inactivation does not encom-
pass the entire integration site, as the cells are grown
continuously in the presence of hygromycin. Progressive
silencing of stable integrated transcription units contain-
ing the human CMV immediate-early promoter/enhancer
has been reported previously [17]. Our data show that the
P2 promoter of the HNF4α gene is not silenced upon
long-term induction (data not shown) demonstrating that
silencing of transgenes is dependent on the promoter type
as previously reported [18,19].
To get a tetracycline-inducible P2 promoter we inserted
the tet operator sequences just downstream of the TATA
box in analogy to the CMV promoter. For unknown rea-
sons this modified P2 promoter is poorly inducible by tet-
racycline. We are not aware of successful tetracycline
regulation for any polymerase II promoter except the
CMV promoter, although tetracycline control of RNA III
polymerase promoters is well established [20].
Applying two improved conditional systems we extended
our previous results by showing that even a small increase
in HNF4α is sufficient to induce apoptosis in the pancre-
atic β-cell line INS-1 [5]. A functional role of HNF4α in
apoptosis seems to be a β-cell restricted effect, as overex-
pression of HNF4α in hepatoma cells [21], embryonic F9
cells [22] as well as in HEK293 cells [12] exclusively affects
cell proliferation. Whether this apoptotic effect of HNF4α
plays an essential role in the endocrine pancreas in vivo,
is presently unknown.
Methods
Plasmid constructs
Details are given in additional file 2.
Establishment of INS-1 Flp-In T-REx cell lines
Establishment and culturing of the Flp-In T-REx INS-1
host cell lines used, #1-1.2 and #5-3.19, was as previously
described [3]. Stable INS-1 Flp-In T-REx cell lines carrying
the inducible transgenes were generated essentially as
described in the Flp-In™ T-REx™ Core Kit Manual (Invitro-
gen). Co-transfection of the Flp expression vector pCS-
FLPe with the pcDNA5/FRT/TO vector containing the
gene-of-interest was carried out using lipofectamine (Fa.
Invitrogen) and hygromycin-B (Fa. Roth) (150 μg/ml)
selection.
Western blotting and immunofluorescence
The anti-myc tag antibody 9E10 was used for detection of
myc-conjugated proteins, and the HNF4α-(C19)-anti-
body (Santa Cruz, Heidelberg, Germany, Nr. sc-6556) was
employed for detection of HNF4α. For Western blots, per-
oxidase-coupled monoclonal mouse-anti-goat/sheep IgG,
Clone GT-34 (Sigma-Aldrich, Saint-Louis, Missouri, USA,
Nr. A9452) was employed as secondary antibody for the
detection of HNF4α using the ECL system (Amersham
Biosciences). For immunofluorescence, Cy3-conjugated
rat anti-mouse [Dianova, Hamburg, Germany; F(ab')2-
fragment, #415-166-166] was used as secondary antibody
for detection of myc.
Caspase activity
Caspase 3 and 7 activity was measured using the Caspase-
Glo™ 3/7 Assay from Promega (Cat.No. G8090). Cells
were plated at a density of 30.000 cells/well for the assay
after 3 days or 10.000 cells/well for the assay after 5 days
in white-walled 96-well plates. Prior to measurement in a
luminometer (GENios multimode research reader; Tecan,
Crailsheim, Germany) cells were incubated with Caspase-
Glo™ 3/7 reagent for 1 h.BMC Research Notes 2009, 2:210 http://www.biomedcentral.com/1756-0500/2/210
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HNF4α2 expression upon long-term induction. Immunofluorescence of 
Flp-In INS-1 α2/CMV-138#1 cells after induction with 50 ng/ml tetra-
cycline.
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Additional file 2
Plasmid constructs (Methods). The text provided describe the cloning of 
all plasmid constructs used in this study.
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